Combined utility of p16 and BRAF V600E in the evaluation of spitzoid tumors: Superiority to PRAME and correlation with FISH.
John L McAfeeRichard ScarboroughXuefei Sophia JiaElizabeth M AzzatoCaroline AstburyShira RonenAleodor A AndeaSteven D BillingsJennifer Susan KoPublished in: Journal of cutaneous pathology (2022)
) uncommonly have meaningful FISH abnormalities (11%). PRAME may have limited utility in this setting.
Keyphrases